Wendell Amy McBride 4

What Happened
Amy McBride, a director of Hologic, Inc. (HOLX), was granted 3,190 restricted stock units (RSUs) on 2026-02-26. The grant is reported as an award (Form 4 code A); no per-share price or immediate cash value is listed because these are equity awards rather than open-market purchases or sales. The RSUs vest on the date of the 2027 Annual Meeting of Stockholders and will be settled one-for-one in Hologic common shares upon vesting.

Key Details

• Transaction date: 2026-02-26 (Grant reported on Form 4 filed 2026-03-02).
• Transaction type: Award of 3,190 RSUs (code A). No per-share price or cash value reported at grant.
• Vesting/settlement: RSUs vest at the 2027 Annual Meeting and are settled one-for-one in common stock (footnotes F1 & F2).
• Shares owned after transaction: Not specified in the provided filing details.
• Filing timeliness: Form 4 was filed 2026-03-02 for a 2026-02-26 grant; this filing appears timely (within the standard two-business-day reporting window).

Context
RSU grants to directors are typically long-term compensation/retention awards and do not represent an immediate market purchase or sale. Because these units vest in the future and convert to shares at a one-for-one ratio, they do not by themselves signal an immediate change in insider selling or buying behavior.